Fig. 8From: miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathwaymiR-145 improved the inhibition effects of DDP on the growth of xenografts. a Tumors from the xenograft treated with different ways for 30 days. b The tumor weight from the xenografts. c The tumor volume of each group at the end of treatment. d Immunohistochemical detection of Ki-67. e Quantification of Ki-67 positive rate. All the results were shown as mean ± SD (n = 3), which were three separate experiments performed in triplicate. *p < 0.05 and **p < 0.01Back to article page